The acid-sensitive potassium channel TASK-1 in rat cardiac muscle

Cardiovasc Res. 2007 Jul 1;75(1):59-68. doi: 10.1016/j.cardiores.2007.02.025. Epub 2007 Feb 28.

Abstract

Objective: The outward current flowing through the two-pore domain acid-sensitive potassium channel TASK-1 (I(TASK)) and its inhibition via alpha1-adrenergic receptors was studied in rat ventricular cardiomyocytes.

Methods: Quantitative RT-PCR experiments were carried out with mRNA from rat heart. Patch-clamp recordings were performed in isolated rat cardiomyocytes. TASK-1 and other K+ channels were expressed in Xenopus oocytes to study the pharmacological properties of a new TASK-1 channel blocker, A293.

Results: TASK-1 channels were found to be strongly expressed in rat heart. Analysis of the sensitivity of various K+ channels to A293 in Xenopus oocytes showed that at low concentrations A293 was a selective blocker of TASK-1 channels. I(TASK) in rat cardiomyocytes was dissected by application of A293 and by extracellular acidification to pH 6.0; it had an amplitude of approximately 0.30 pA/pF at +30 mV. Application of 200 nM A293 increased action potential duration (APD(50)) by 31+/-3% at a stimulation rate of 4 Hz. The plausibility of the effects of A293 on APD50 was checked with a mathematical action potential model. Application of the alpha1-adrenergic agonist methoxamine inhibited I(TASK) in Xenopus oocytes co-injected with cRNA for TASK-1 and alpha1A-receptors. In cardiomyocytes, methoxamine inhibited an outward current with characteristics similar to I(TASK). This effect was abolished in the presence of the alpha1A-antagonist 5-methyl-urapidil.

Conclusions: Our results suggest that in rat cardiomyocytes I(TASK) makes a substantial contribution to the outward current flowing in the plateau range of potentials and that this current component can be inhibited via alpha1A-adrenergic receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Calcium Channel Blockers / pharmacology
  • Computer Simulation*
  • Hydrogen-Ion Concentration
  • Methoxamine / pharmacology
  • Models, Cardiovascular*
  • Myocardium / metabolism*
  • Nerve Tissue Proteins
  • Oocytes / metabolism
  • Patch-Clamp Techniques
  • Piperazines / pharmacology
  • Potassium Channels, Tandem Pore Domain / antagonists & inhibitors
  • Potassium Channels, Tandem Pore Domain / genetics
  • Potassium Channels, Tandem Pore Domain / metabolism*
  • RNA, Messenger / analysis
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection / methods
  • Xenopus laevis

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Calcium Channel Blockers
  • Nerve Tissue Proteins
  • Piperazines
  • Potassium Channels, Tandem Pore Domain
  • RNA, Messenger
  • 5-methylurapidil
  • potassium channel subfamily K member 3
  • Methoxamine